Immediate Impact
71 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Extracellular vesicles as tools and targets in therapy for diseases
2024 Standout
Works of Y-L. Choi being referenced
ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cellsThis article has been corrected since Advance Online Publication and an erratum is also printed in this issue
2017
Clinical significance of CD151 overexpression in subtypes of invasive breast cancer
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Y-L. Choi | 64 | 66 | 101 | 84 | 7 | 259 | |
| Rachel Wachsmuth | 175 | 71 | 166 | 18 | 7 | 294 | |
| Timothy Lax | 46 | 118 | 55 | 37 | 10 | 304 | |
| T.O. Bleiker | 32 | 51 | 89 | 30 | 10 | 201 | |
| Monica Bhushan | 47 | 67 | 109 | 19 | 7 | 291 | |
| Parrish Sadeghi | 122 | 50 | 93 | 18 | 8 | 282 | |
| Yora Mostmans | 22 | 63 | 83 | 26 | 11 | 285 | |
| Ruediger Hein | 27 | 27 | 155 | 61 | 5 | 228 | |
| Ulf M�ller-Ladner | 59 | 73 | 41 | 11 | 8 | 318 | |
| Sasha D. Girouard | 140 | 148 | 86 | 23 | 10 | 307 | |
| C Hager | 44 | 64 | 114 | 9 | 7 | 267 |
All Works
Loading papers...